During an immune response, activated B cells may undergo class switch recombination (CSR), a molecular rearrangement that allows B cells to switch from expressing IgM and IgD to a secondary antibody heavy chain isotype such as IgG, IgA or IgE. Secondary antibody isotypes provide the adaptive immune system with distinct effector functions to optimally combat various pathogens. CSR occurs between repetitive DNA elements within the immunoglobulin heavy chain (Igh) locus, termed switch (S) regions and requires the DNA-modifying enzyme activation-induced cytidine deaminase (AID). AID-mediated DNA deamination within S regions initiates the formation of DNA double-strand breaks, which serve as biochemical beacons for downstream DNA repair pathways that coordinate the ligation of DNA breaks. Myriad factors contribute to optimal AID targeting; however, many of these factors also localize to genomic regions outside of the Igh locus. Thus, a current challenge is to explain the specific targeting of AID to the Igh locus. Recent studies have implicated noncoding RNAs in CSR, suggesting a provocative mechanism that incorporates Igh-specific factors to enable precise AID targeting. Here, we chronologically recount the rich history of noncoding RNAs functioning in CSR to provide a comprehensive context for recent and future discoveries. We present a model for the RNA-guided targeting of AID that attempts to integrate historical and recent findings, and highlight potential caveats. Lastly, we discuss testable hypotheses ripe for current experimentation, and explore promising ideas for future investigations.
Introduction
Following initial exposure to an immunogen, the adaptive immune system provides a mechanism to activate antigenspecific B cells in order to produce antibodies and facilitate an immune response. Antibodies are secreted forms of the B cell antigen-receptor (BCR) and are composed of immunoglobulin (Ig) heavy (IgH) and light (IgL) chains; the N-terminal region of the IgH and IgL chains comprise the antigen-recognition domain, whereas the C-terminal domain of IgH mediates downstream signaling and effector functions following antigen binding (Fig. 1) .
A hallmark of the adaptive immune system is the ability to recognize a vast array of antigens, a property mediated by the diverse repertoire of B cell Ig sequences. This diversity is created in part through V(D)J recombination, a process that assembles the N-terminal variable (V), diversity (D) and joining (J) segments in different combinations. Following the completion of V(D)J recombination, mature B cells exit the bone marrow and migrate to secondary lymphoid organs where they may encounter antigens, become activated and undergo class switch recombination (CSR).
CSR is a molecular rearrangement that deletes and recombines portions of the immunoglobulin heavy chain (Igh) locus, exchanging the default C μ constant region (C H ) gene segment for an alternate set of C H genes (C γ , C ε , C α ). CSR occurs between repetitive DNA elements, termed switch (S) regions, which precede each C H gene segment, and requires the DNAmodifying enzyme activation-induced cytidine deaminase (AID) (1) (2) (3) . AID deamination within S regions initiates the formation of DNA double-strand breaks (DSBs) (4, 5) , which are then repaired primarily by non-homologous end-joining [reviewed in (6) ] (Fig. 2A ). This acts to simultaneously excise the intervening C H segments and juxtapose the upstream V(D)J region with a new downstream C H . The excised fragment can ligate to form a closed circle that will undergo transcription and processing, and whose presence is a molecular proxy for CSR (Fig. 2B) .
CSR thus enables a B cell to switch from expressing default IgM and IgD to a secondary heavy chain isotype, providing the adaptive immune system with distinct effector functions and properties to optimally combat a vast array of pathogens it may encounter.
Understanding the biochemical properties and molecular mechanisms that govern AID targeting has been paramount since its discovery, partly because of the implications that aberrant AID targeting has in the genesis and treatment of B cell malignancies (7) . Nearly two decades of research have revealed myriad factors that contribute to AID targeting, including protein-protein interactions, protein-nucleic acid interactions and megabase-scale chromatin organization and looping [CSR and AID targeting reviewed extensively in (6, 8, 9) ]. While these factors undoubtedly contribute to efficient AID targeting and CSR, many do not localize specifically to the Igh locus. A current challenge is to decipher how this complex milieu of molecular interactions supports efficient AID targeting to the Igh locus, while minimizing deleterious mis-targeting driven by the same processes.
The CSR field arose with a cluster of discoveries that identified noncoding RNAs emanating from the Igh locus. Recent studies have highlighted new roles for these RNAs in targeting AID (10) (11) (12) , and suggest a provocative mechanism that contributes to Igh-specific targeting (10) analogous to CRISPR-Cas9 gene editing. Amidst a growing paradigm of noncoding RNAs targeting DNA-or chromatin-modifying factors (13) , recounting the bountiful history of CSR and noncoding RNAs serves to highlight the significance of recent findings while providing an opportunity to spark new ideas.
Here, we aim to provide a comprehensive, chronological review of noncoding RNAs and transcription in AID targeting, focusing largely on CSR. We begin with the discovery of Igh noncoding transcripts and the mystery of their role in CSR. Next, we examine the biochemical properties of these transcripts, with a focus on their ability to form R-loops, or RNA/ DNA hybrids and secondary structures like G-quadruplexes. We then examine transcription-related factors, as well as the RNA molecules themselves, demonstrated to contribute to AID targeting. We conclude with a model for RNA-guided AID targeting, and highlight the important questions, caveats and hypotheses this model evokes.
Prelude to transcription
Over 40 years ago, Klinman and colleagues (14) used the splenic focus system to show that a single B cell clone could produce antibodies of multiple isotypes, but with an identical variable region. Building upon previous findings that a single B cell could have both surface IgM and cytoplasmic IgG (15), secrete both IgM and IgG (16) and single-cell-derived splenic foci could produce monoclonal antibodies containing both IgM and IgG1 (17) , the biological phenomenon of CSR was laid bare for the emergent field to unravel. Merely 3 years later, Honjo and Kataoka (18) utilized myeloma tumor lines expressing various IgH isotypes to describe the linear organization of the Igh locus and presciently postulate the 'allelic deletion' model for CSR.
Spurred by these groundbreaking discoveries, the developing CSR field progressed rapidly through the turn of the century, evolving in response to major discoveries and intertwining with various fields such as splicing, DNA damage and repair and chromatin biology. The discovery of AID and its essential role in antibody diversification (1-3) kindled the ensuing debate over AID's nucleic acid substrate, inspiring the DNA deamination model (5) and precipitating the identification of downstream players in the CSR pathway such as the DNA glycosylase UNG (19) . In turn, this discovery fueled a race to uncover single-stranded DNA (ssDNA) as the target of AID's enzymatic activity, as well as the dependence on transcription for deamination (20) (21) (22) (23) (24) . However, nearly two decades before AID and UNG, there was the peculiar observation that noncoding RNA transcripts originated from within the Igh locus, and the notion they may be playing a role in CSR.
Uncovering germline transcripts, starting with T cells
Early studies on B cell tumor lines first characterized the expression of two differentially spliced C μ mRNAs representing either membrane (μ m ) or secreted forms (μ s ) (25) (26) (27) . However, studies searching for immunoglobulin expression in T cells (pre-dating the discovery of the T cell antigen-receptor) first observed C μ -containing transcripts differing in size to μ m and μ s (28, 29) . Northern blot analyses using probes spanning C μ revealed these alternative transcripts underwent splicing, and while similar to μ m and μ s at their 3′ ends, their 5′ ends originated within the J H -C μ intron and did not include a variable region (30) (Fig. 3) .
Additional studies using transformed B cell lines also detected C μ containing RNAs lacking variable regions, designating them as either 'sterile' or 'I μ ' transcripts, hereafter termed germline transcripts (GLTs) (31, 32) . C μ GLTs were found to originate at heterogeneous sites downstream of the C μ enhancer (E μ ) and promoter region, and contained a cryptic splice site ~700 bp downstream of initiation. This created an exon, now referred to as the intervening or 'I-exon', that was spliced to the 5′ C μ constant region (32) (Fig. 3) .
Experimentation on transformed B cell lines continued to fuel CSR discoveries; the isolation of pure IgM + cells from the I.29 mouse B cell lymphoma, which contained a mixture of cells expressing membrane-bound IgM and IgA of the same idiotype (33, 34) , was a key breakthrough. IgM + cells could be induced to undergo CSR in vitro to IgA, IgE or IgG2b by treatment with LPS in combination with a monoclonal antibody raised against the I.29 Ig idiotype (35) . This crucially allowed a controlled comparison of GLTs and genomic rearrangements at the Igh locus before, during and after CSR. Amongst the first clues that GLTs functioned during CSR was the detection of RNAs transcribed from an unrearranged C α region in IgM + I.29 cells undergoing IgA CSR (36) . These observations extended to other isotypes as well; in Abelson murine leukemia virus (A-MuLV)-transformed pre-B cell lines, expression of C γ2b GLTs preempted IgG2b CSR (37) .
A flurry of studies followed examining the influence of various mitogens and cytokines on GLTs. LPS was shown to induce C γ2b and C γ3 GLTs prior to IgG2b and IgG3 CSR, respectively, whereas IL-4 had an inhibitory effect on these GLTs (38, 39) . Alternatively, IL-4 induced C γ1 and C ε GLTs prior to the appearance of membrane-bound IgG1 and IgE mRNAs, respectively (39) (40) (41) (42) (43) (44) . IFNγ induced C γ2b GLTs, but repressed C γ1 and C ε GLTs (39, 45, 46) , and TGFβ increased C α GLTs and IgA CSR, but repressed C ε GLTs (45, 47) . The observed cytokine-induced transcription of GLTs was rapid; C γ1 and C ε transcripts were detected only 4 hours after cytokine stimulation (42, 43) .
These studies established an overwhelmingly clear consensus within the field: mitogens and cytokines directed CSR to particular isotypes by activating germline transcription upstream of the desired C H region, and in some cases abrogating transcription in undesired C H regions. This prompted the idea that activation of chromatin regions could provide access not only to RNA polymerases, but also to a yet unidentified recombinase (it would be more than a decade before AID was discovered). Notably, the concept of transcription priming recombination was heavily influenced by findings of unrearranged variable regions undergoing transcription prior to rearrangement (48, 49) , the observation that transcription could enhance variable region recombination (50) and the positive correlation between transcription and recombination in Saccharomyces cerevisiae (51) . Indeed, the magnitude of C α GLTs was shown to correlate directly with I.29 clones that had increased IgA CSR (40) .
Molecular cloning reveals conserved GLT structure
Simultaneous to the mitogen and cytokine studies, parallel efforts were honing in on defining the molecular structure and function of the various GLTs. The C γ2b GLT was first cloned from A-MuLV-transformed cells, demonstrating the transcripts initiated 5′ of C γ2b , in accord with previous findings of C μ GLTs (32, 52) . The cloning of GLTs from C α (47, 53), C ε (44, 54) and C γ3 (55) was rapidly published within the next year. Additionally, the discovery of regulatory DNA elements abutting transcription initiation sites in C H loci revealed sequences that conferred LPS and IL-4 responsive transcription (56) .
Strikingly, these studies uncovered conserved features within all GLTs: initiation of transcription upstream of the S region, the presence of an I-exon 5′ to the S region that was unlikely to code for a protein, and splicing of this exon to the 5′ exon of the downstream C H gene (Fig. 3 ). Stavnezer and colleagues succinctly characterized the implications of these findings:
'The fact that the germ line transcripts that have been characterized have similar structures argues that their transcription does have a function and is not simply an accidental by-product of the accessibility of the C H gene.' (53)
Molecular peculiarities of S regions
Due to the observation that breakpoints in CSR occurred within the intronic S regions of C H genes (57), a leading hypothesis was that S region sequences possessed unique characteristics that targeted CSR. Mouse S regions are composed of 1-10 kilobases (kb) of tandem repeats that are G-rich on the nontemplate strand DNA (57, 58) . Both the sequence and number of tandem repeats vary between different mouse C H S regions. S μ , S α and S ε are composed of pentameric repeats, whereas S γ1 , S γ2b and S γ3 are composed of longer 49 bp repeats (59-64) (reviewed in (57)). A notable exception is the non-canonical switch-like region located upstream of C δ , referred to as σ δ . On rare occasions, recombination between S μ and σ δ results in IgD CSR, producing a B cell solely expressing IgD (65) (66) (67) (68) . The intronic S regions are excised from GLTs during splicing, connecting the I-exon to a downstream C H exon (Fig. 3) .
Among the seminal studies of the molecular properties of S sequences, Wells and colleagues cloned various G-rich S α repeats into a plasmid in a search of peculiar DNA structures (69) . By assaying the sensitivity of S α repeats to S1 and P1 nucleases, as well as a battery of chemical probes including dimethyl sulfate, bromoacetaldehyde, osmium tetroxide and diethyl pyrocarbonate, Wells and colleagues concluded that S α repeats adopted a non-B-DNA structure, suggesting a potential intramolecular triple-strand (69) . Aiming to identify proteins that specifically bound to S sequences, Sen and Gilbert (70) fortuitously observed that purine-rich S sequence ssDNA fragments migrated unexpectedly during electrophoretic mobility shift assays. Intriguingly, the complementary pyrimidine-rich strand did not exhibit a similar migration. Dimethyl sulfate treatment revealed stretches of Gs that were completely protected from methylation, suggestive of Hoogsteen bonding (71) , and leading to a paradigmatic model of a parallel, four stranded structure, termed 'G4-DNA' (70). By the early 1990s, the potential role of GLTs in CSR had become a major focus of the field, leading S region structure studies to broaden their purview to include transcription-induced structures. In a landmark study, Reaban and Griffin (72) observed that transcription of a supercoiled plasmid containing 2.3 kb of S α sequence curiously led to a loss of supercoiling. Intriguingly, supercoiling relaxation only occurred when S α was transcribed in the physiological orientation. Treatment of transcribed plasmids with various nucleases revealed sensitivity to RNase H and mung bean nuclease, suggesting the presence of an RNA-DNA hybrid and ssDNA (collectively referred to as an R-loop). Treatment with RNase H abolished sensitivity to mung bean nuclease, suggesting that formation of the RNA-DNA hybrid was necessary for the presence of ssDNA. Addition of S α transcripts without polymerase did not lead to altered mobility, suggesting that the observed R-loop was transcription-dependent (72) . In the context of the previously hypothesized S region DNA intramolecular-triple strand (69, 70), Reaban and Griffin postulated a model whereby transcription leads to formation of an R-loop (Fig. 4A ), which then helps to stabilize the DNA triple-strand (72) . Further work from Griffin and colleagues found that the S α R-loops could extend up to 140 nucleotides, formed independently of supercoiling, and were remarkably stable, withstanding temperatures up to 95°C (73) .
Building upon the S α studies (72, 73) , transcription of S μ , S γ2b and S γ3 sequences also formed stable R-loops in vitro, and only when transcribed in the physiological orientation (78, 79) . Similar to S α (72), these R-loops were also remarkably stable, persisting after phenol-chloroform extraction, Transcription through S regions leads to the formation R-loops, consisting of an RNA-DNA hybrid and G-rich non-template single-stranded DNA (ssDNA). R-loops can extend over 1000 bp, as well as several hundred base pairs upstream of S regions. Current models hypothesize the availability of ssDNA is a key factor in targeting activation-induced cytidine deaminase (AID) to R-loops. (B) Table quantifying the contribution of R-loops to class switch recombination. Data were extracted from three studies that compared the ability of various S regions to potentiate IgG1 class switch recombination (CSR) at the endogenous mouse locus, with that of their inverted sequences (74) (75) (76) . Because the inverted sequences do not support R-loop formation but are identical in size and sequence, an analysis of these comparisons can indicate the contribution of R-loops to CSR. This analysis was posited by Lieber and colleagues (77) , and extended to include additional studies. 'R-loop?' indicates if the sequence has been shown to form an R-loop. '%CSR' indicates the relative IgG1 CSR frequency, which is defined by the ratio of allele-specific hybridomas produced in various S region replacements, compared with that of the wild-type S γ1 sequence. '%CSR of control' indicates the frequency of CSR supported by inverted sequences relative to their non-inverted controls. kb, kilobase; syn, synthetic; AID, activation-induced cytidine deaminase.
protease treatment and temperatures up to 65°C (78) . Most importantly, all S regions examined formed stable R-loops, suggesting a conserved mechanism during CSR and leading Reaban and Griffin to conclude: 'The formation of such RNA-DNA hybrids in transcriptionally active switch regions may be important in switch recombination.' (72)
Extrachromosomal recombination assays support a role for S region transcription
Early studies demonstrated that retroviral integration of S sequences could mediate recombination in pre-B cell lines (80) , paving the road for the extrachromosomal recombination assay. In this assay, DNA substrates containing S region sequences flanking a lethal marker gene are transfected into B cells, which are then stimulated with cytokines to undergo CSR. Recombination between extrachromosomal S regions deletes the intervening lethal gene, allowing for recovery and selection of substrates in Escherichia coli. This provided a valuable tool to quickly assay the ability of various S region sequences, promoters, transcriptional orientations and cell lines to promote CSR.
In primary B cells, the addition of a promoter upstream of S regions led to a 10-fold increase in extrachromosomal recombination, and was dependent on a G-rich non-template strand (81) . Extrachromosomal recombination occurred at significantly higher rates when S region transcription occurred in the physiological orientation (82), although some recombination was observed to occur between S μ in the forward direction and S α in reverse (83) . Additionally, extrachromosomal substrates underwent more efficient recombination in B cell lines versus T cell or non-lymphoid lines, supporting the idea of a B cell-specific recombination factor (AID was still 5 years from discovery) (82, 84) .
Modifying C H loci to better understand GLTs
Multiple lines of evidence accumulated implicating a role for GLTs in CSR. The conserved structure of GLTs, as well as the ability of all S regions to form R-loops, strongly implied a conserved function for transcription through C H loci. To formally address this, the CSR field heavily relied upon the genetic modification of C H loci within mouse embryonic stem (ES) cells. Modified ES cells were then injected into blastocysts, leading to the development of chimeric mice with altered C H loci. Initially, large sections of C H regions were removed to determine the role of GLTs in CSR.
Deletion of 1.7 kb located 5′ of S γ1 removed promoter elements, the I γ1 -exon and splice donor site, leading to a complete loss of IgG1 CSR. Intriguingly, in mice heterozygous for the targeted allele, wild-type alleles could undergo normal CSR, suggesting GLTs were unable to act in trans on the targeted allele (85) . Similarly, replacement of the promoter and I γ2b -exon with a bacterial neomycin resistance gene in the opposite transcriptional orientation completely blocked C γ2b GLTs and IgG2b CSR in homozygous mice (86) . Lastly, deletion of a region including J H segments as well as E μ led to the absence of C μ GLTs and severely disrupted IgG1 CSR (87) .
While the C μ locus was impaired in this study, the downstream C H genes remained intact. Intriguingly, the S γ1 region was still rearranged upon stimulation to induce IgG1 CSR, resulting from internal S γ1 deletions (87) .
Collectively, these studies demonstrated the importance of transcription at both donor and acceptor C H regions to mediate efficient CSR, and that regulation of transcription at donor and acceptor C H regions occurred independently.
Building on these results, subsequent studies aimed to precisely replace different elements within C H genes while maintaining transcription. This would specify if GLTs per se, versus transcription in general, was required for CSR. Alt and colleagues replaced the LPS-IL4 responsive element and I ε -exon with either the Igh enhancer and V gene promoter, or an LPS inducible E μ enhancer and V gene promoter. The former manipulation lead to constitutive transcription from the C ε locus and the ability to undergo some degree of CSR to IgE in the absence of IL-4, as measured by PCR-based assay (88) . This suggested that transcription through the C ε locus, as opposed to other IL-4 responsive elements or the I ε exon itself, was sufficient to permit detectable levels of IgE CSR. The latter manipulation lead to LPS-responsive transcription and 10-100-fold lower CSR as measured by flow cytometry and IgE secretion (89) . Together, these studies suggested that transcription per se was sufficient to support detectable levels of CSR; however, an intact I-exon and/or promoter regions were necessary for optimal CSR.
A crucial study focusing on the C γ1 locus suggested a potential role for the splicing of GLTs in promoting CSR. A 5′ region containing the IL-4 responsive promoter and the I γ1 -exon was replaced with a human metallothionein (hMT) II A promoter and IgG1 CSR was measured in mice with or without the presence of a 114-bp fragment of the I γ1 -exon containing the splice donor site. Mice with the splice donor site underwent comparable IgG1 CSR to wild-type controls, whereas those lacking the splice donor site did not. Control experiments demonstrated that mice with and without the splice donor site had equal rates of S γ1 transcription as measured by nuclear run-on assay. However, the quality of C γ1 GLTs, assayed by northern blot analysis with hMT probes, was severely compromised in those lacking the splice donor site (90) .
These results built upon previous findings from Alt and colleagues (88, 89) , suggesting the I-exon was not required for CSR. Additionally, they demonstrated that stable S γ1 GLTs were sufficient to confer optimal CSR, and suggested a critical role for splicing. Radbruch and colleagues concluded:
'The most intriguing speculation is that switch transcripts are part of the switch recombinase, providing the specificity to target distinct switch regions.' (90) A study manipulating the C α locus provided a wrinkle to the evolving role of GLTs in CSR. Davis and colleagues replaced a 1.4-kb region of the C α locus with a human hypoxanthine phosphoribosyltransferase (HPRT) minigene, deleting the entire I α exon and splice donor site, while leaving the C α promoter intact (91) . Surprisingly, this did not affect IgA CSR as measured by surface IgA staining and IgA secretion. These data initially appeared to conflict with Radbruch and colleagues' previous findings (90) because of the absence of the I α splice donor site. However, Davis and colleagues noted that the HPRT minigene contained an intron and was transcribed in the physiological direction, leading to the detection of HPRT transcripts. This suggested that transcription through the S α sequences and subsequent splicing may occur; however, an assay was not performed to confirm the presence of S α containing GLTs (91) .
Radbruch and colleagues (90) noted an important caveat within their initial study; the 114-bp fragment of the I γ1 -exon may have contained a critical recombination control element in addition to the splice donor site. To address this caveat and the recent data from Davis and colleagues (91), Radbruch and colleagues performed an elegantly controlled study. They replaced the endogenous C γ1 promoter, I γ1 -exon and splice donor site with heterologous components: a hMT promoter, a bacterial sequence derived I-exon and an adenoviral splice donor site (92) . While absence of the splice donor site completely disrupted CSR, addition of the wild-type or heterologous splice donor site was sufficient to restore IgG1 CSR to appreciable levels (92) . This unequivocally demonstrated that the I γ1 -exon or surrounding sequences did not contain a recombination element, in agreement with Davis and colleagues' conclusions on the I α -exon (91) .
It is important to reiterate that mice lacking the I γ1 splice donor site were deemed transcriptionally active via nuclear run-on assays, however, no stable GLTs were detected by northern blot analysis of total RNA (90) . This suggests the absence of a splice donor site prevented the stable transcription of the downstream S γ1 region and C γ1 exons. Thus, it was impossible to distinguish between the requirements of splicing per se, from that of stable S γ1 GLTs. Nonetheless, in light of recent findings on the role of S region transcripts (10) (discussed in detail later), Radbruch and colleague's conclusions would hit their mark:
'Either the processing machinery or the processed transcripts are involved in class switch recombination.' (92) In corroboration, Alt and colleagues (93) performed an analogous study to Davis and colleagues (91) , replacing the I γ2b -exon and splice donor site with a bacterial neomycin resistance gene transcribed in the physiological orientation. They found that IgG2b CSR was unperturbed in ES cellderived chimeric mice, and crucially demonstrated the presence of S γ2b -containing transcripts. This led to the notion that transcription through S regions may be sufficient to enable CSR, although Alt and colleagues (93) noted that the presence of cryptic splice sites within the neomycin resistance gene might have also contributed. In a parallel study of the C μ locus, insertion of a neomycin resistance gene similarly rescued a CSR defect caused by deletion of E μ and other C μ control elements (94) .
Over a span of 5 years, these studies collectively modified the C μ (87, 94), C γ1 (85, 90, 92) , C γ2b (86, 93), C ε (88, 89) and C α (91) transcriptional control elements in order to better understand the role of GLTs. These pivotal studies strongly suggested that transcription of C H loci, and more precisely the generation of stable S transcripts, was necessary for efficient CSR. Importantly, the dependency on transcriptional orientation was in accord with results from R-loop and extrachromosomal recombination studies, and overwhelmingly pointed to a precise role for the G-rich S regions transcripts in targeting CSR.
An activation-induced interlude
The identification of AID by cDNA subtractive hybridization in the CH12 B cell line was a momentous discovery (1) . AID was shown to be required for both CSR and somatic hypermutation (SHM) in a mouse knock-out model (2), and AID deficiency was linked to hyper-IgM syndrome and a lack of SHM in humans (3) . Within the span of 3 months, five independent groups demonstrated that ssDNA was the molecular target of AID's deaminase activity (20) (21) (22) (23) (24) . Transcription was shown to induce AID deamination activity on the nontemplate strand of dsDNA (20, 23, 24) , and the specific deamination of S regions was dependent upon transcription in the physiological orientation (20) . The role of GLTs and R-loops in CSR were now reassessed from a new molecular perspective: how do these molecules facilitate AID targeting to S regions?
R-loops in an AID world
S region R-loops were hypothesized as vital molecular structures responsible for exposing ssDNA targeted by AID during CSR (Fig. 4A ). R-loops had been detected in vitro using a wide variety of techniques including atomic force microscopy (95); however, it was unknown if they occurred in vivo and if they were necessary for CSR. To identify R-loops at endogenous S regions, Lieber and colleagues developed a technique that coupled sodium bisulfite treatment of nucleic acids with DNA sequencing (96) . Sodium bisulfite selectively deaminates single-stranded cytidines, converting them into uridines, which can be detected and quantified using PCR amplification and DNA sequencing. In a sodium bisulfite experiment, sequenced clones containing long stretches of C to U conversion are indicative of R-loop formation throughout a locus.
Lieber and colleagues applied this technique to detect R-loops formed during in vitro transcription of various S region templates. They found that transcription of S γ3 repeats led to long stretches (>100 bp) of conversion along the G-rich non-template strand, but not the C-rich strand (96) . This was dependent upon the transcriptional orientation, as previously observed for S region R-loop formation (72, 73, 78, 79) . Lieber and colleagues adapted their protocol to boost sensitivity, and remarkably detected long stretches of conversion extending upwards of 1 kb in length at the endogenous S γ3 and S γ2b regions in primary B cells stimulated with LPS (96) .
The remarkable length and stability of R-loops is understandable considering the known thermodynamic properties of nucleic acids: purine-rich RNA can form a more stable duplex with pyrimidine-rich DNA than purine-rich DNA forms with pyrimidine-rich DNA (97, 98) . Likewise, the dependence upon transcription in the physiological orientation is consistent with the observation that purine-rich RNA can form a more stable duplex with pyrimidine-rich DNA, than pyrimidine-rich RNA does with purine-rich DNA (97, 98) .
The majority of S γ3 and S γ2b R-loops were found to occur within S regions, and some were detected spanning the entire 2 kb S γ3 region (99) . R-loops could extend up to 600 bp downstream of S regions; however, the declining G-richness of the non-template strand outside of S regions was hypothesized to play a major role in demarcating R-loop boundaries (99) . In accord, reduction of G density from 46 to 29% on the nontemplate strand was found to decrease both R-loop length and CSR in CH12 cell lines (100) . Additionally, the pattern of AID deamination in ung -/-msh -/-mice (which lack uracil-DNA glycosylase and a mismatch-recognition protein) revealed long stretches of mutations within S μ that correlated with the locations of R-loops (101, 102) , strongly supporting a role for R-loops targeting AID.
The importance of S regions in CSR
Previous genetic manipulations of C H regions clearly suggested that transcription of S regions was a critical determinant for efficient CSR. The formation of R-loops within S regions now provided a mechanistic outcome for the requirement of transcription. However, the precise requirement for endogenous S regions had not been firmly established. Alt and colleagues addressed this gap in knowledge by deleting, inverting or replacing 12 kb of the S γ1 region, including 8 kb of conserved S γ1 repeats (74) . Importantly, transcription and splicing of GLTs from the modified S γ1 loci were unaffected during these perturbations. Analysis of allele-specific ELISAs and hybridomas revealed that deletion of the S γ1 region resulted in a near complete loss of IgG1 CSR. Inversion of S γ1 decreased IgG1 CSR to approximately 25% of wild-type levels (74) , in agreement with R-loop formation only occurring during transcription in the physiological orientation (72, 73, 78, 79, 96) .
Intriguingly, replacement of the S γ1 region with 1 kb of random, non-repetitive G-rich sequence reduced CSR to 7% of wild-type levels, in spite of being approximately 10% the length of wild-type S γ1 . The inversion of this sequences to produce a C-rich transcript was unable to support detectable levels of CSR (74) . These results were in accord with the in vitro formation of R-loops during transcription of the G-rich, but not C-rich RNA sequence (74) . This suggested specific S region motifs were not required, as a random sequence could support appreciable levels of CSR. It also supported the concept that the most important consequence of S region transcription was the formation of R-loops and subsequent exposure of ssDNA.
Studies replacing the endogenous S γ1 region with 1, 2 or 4 kb of S γ1 repeats demonstrated a direct correlation between S region length and CSR efficiency (75) . Additionally, replacement of S γ1 with 2 kb of S γ3 , or 2 kb of S γ1 as a size-matched control, led to equal IgG1 CSR, suggesting that the various S regions were interchangeable (76) .
I can do anything better than μ?
S region transcription and R-loop formation had convincingly been demonstrated to play a vital role in CSR. However, a handful of studies modifying S μ revealed important details. Deletion of all S μ tandem repeats (ΔS μ TR) (~3 kb) resulted in a 50% decrease in IgG1 CSR, suggesting the core repeats were not necessary, but increased CSR efficiency (103) . In support of this, most ΔS μ TR-derived IgG1 hybridomas had only rearranged the productive Igh allele, whereas wild-typederived hybridomas frequently rearranged both alleles (94, (103) (104) (105) . Because the majority of breakpoints in S γ1 , S γ2b , S γ3 , S ε and S α occur within the tandem repeat regions, this result initially appeared surprising. However, S μ is unique in that approximately 40% of breakpoints fall outside of the tandem repeat region (57) . Supporting this, deletion of all remaining S μ pentameric motifs in addition to the tandem repeat region (ΔI μ -C μ ) resulted in a more severe reduction in CSR (106) .
The CSR phenotype of ΔI μ -C μ and ΔS μ TR B cells correlated with their abilities to form R-loops. Because R-loops were found to initiate hundreds of base pairs upstream of the S μ tandem repeats, the presence of R-loops in ΔS μ TR B cells was no surprise (101) . Predictably, R-loops could not be detected in ΔI μ -C μ B cells. However, in a minority of ΔI μ -C μ cells that were able to undergo successful CSR, breakpoints were found within the I μ -exon. This demonstrated that CSR in the absence of R-loops and the S μ region was possible, albeit at drastically lower levels (106).
What's an R-loop worth to CSR? Ask a frog
Because of its AT-rich non-template strand (unlike G-rich sequences in mammals), the Xenopus laevis S μ (XS μ ) region offered a unique perspective on the precise contributions of R-loops to CSR. Predictably, a 4-kb XS μ region did not support transcription-dependent R-loop formation, although replacement of endogenous mouse S γ1 with 4 kb XS μ supported 25% of wild-type IgG1 CSR in a hybridoma assay (107) .
Insertion of a random 4-kb sequence resulted in a further 10-fold decrease in CSR, suggesting the presence of sequences within XS μ that supported AID targeting independent of R-loop formation (107) . Breakpoint analysis within XS μ identified an enrichment for CSR junctions at or adjacent to 'AGCT' sequences, a variation of the recently characterized 'DGYW' AID hotspot motif (107, 108) . The addition of replication protein A (RPA; this binds ssDNA and stabilizes its structure) was necessary to mediate AID deamination of XS μ sequences in vitro, supporting a model where RPA helps target AID to hotspot motifs in the absence of R-loops to mediate CSR (107) . This model was consistent with the observation that SHM substrates unable to form R-loops required RPA for AID-mediated deamination (109).
AID's function in SHM (occurring in fish, amphibians, birds, mammals) evolved approximately 100 million years before its function in CSR (occurring in amphibians, birds, mammals) (110, 111) . Lieber and colleagues discussed the concept that G stretches within S regions evolved in mammals with CSR to more efficiently produce R-loops, and subsequently increase ssDNA exposure for AID deamination (77) . To quantify the relative contribution of R-loops, Lieber and colleagues (77) cleverly compared CSR frequencies between experiments where S γ1 has been inverted (74) or replaced with XS μ (107). In both cases, sequences supporting R-loops endowed 4-fold higher CSR than sequences that did not. If this analysis is extended to include two additional studies and limited only to various size-matched, inverted S regions (75, 76) , the A transcriptional serenAID 191 average benefit of forming RNA-DNA hybrids is a 3.9 ± 1.2-fold increase in CSR (Fig. 4B) .
These XS μ studies demonstrated that while S region R-loops may have evolved to support more efficient CSR, a high-density of DGYW motifs throughout S regions can support AID deamination through an RPA-dependent, R-loop-independent mechanism. Importantly, both of these mechanisms are transcription dependent.
Deamination of template-strand DNA, in spite of RNA-DNA hybrids R-loops provide a clear mechanism to account for AID targeting of the non-template strand. However, the formation of a thermodynamically stable RNA-DNA hybrid protects the template-strand DNA from deamination. Because AID deaminates both strands of DNA equally during CSR and SHM (102, 112) , it remained a mystery how template-strand DNA strand was efficiently targeted. The RNA exosome was discovered to play an important role in targeting AID to both DNA strands, shedding light on this conundrum.
The RNA exosome is a conserved RNA degradation/processing complex that plays a vital role in RNA metabolism and transcriptional regulation (113) . AID was found to interact with RNA exosome components in extracts from both CH12 and primary B cells stimulated to undergo CSR (11) . Chromatin immunoprecipitation (ChIP) experiments revealed that the core RNA exosome component Exosc3 localized to both S μ and S γ1 in primary B cells stimulated to undergo IgG1 CSR. Strikingly, the addition of purified core RNA exosome components dramatically increased AID deamination of nontemplate strand DNA in vitro (11) .
In a follow-up study, conditional deletion of Exosc3 in B cells decreased both SHM and CSR (114) . Intriguingly, this deletion also revealed myriad transcription start site-associated antisense transcripts that correlated with AID-dependent translocation hotspots. CHiP experiments revealed that AID localized to these regions, and was dependent on the presence of Exosc3. Lastly, these regions also formed RNA-DNA hybrids, which were increased upon deletion of Exosc3 (114) . Of note, the catalytic subunit of the RNA exosome was not required to target deamination of template-strand DNA in vitro (11) . This demonstrated that exonucleolytic removal of the RNA transcript is not required for AID to access the template-strand DNA, suggesting a yet unidentified mechanism.
Together, these studies demonstrate a role for the RNA exosome in targeting AID to loci with RNA-DNA hybrids, as well as mediating its deamination of the template-strand DNA.
In addition to the RNA exosome, RNase H was postulated to mediate template-strand deamination after a particularly curious finding. Surprisingly, treatment of S region R-loops with RNase H increased the amount of sodium bisulfite conversion along the template strand (96) . This suggested that digestion of the hybridized RNA molecule could lead to an abrupt collapse of the R-loop and misalignment of S region repeats, precipitating the exposure of ssDNA to AID (96) . While it is currently unknown if this mechanism occurs in vivo, a recent study overexpressing RNase H in transgenic mice found that CSR was unaffected, but template-strand deamination was marginally increased (115) . More work is required to determine if endogenous levels of RNase H can support this mechanism.
Targeting AID with transcriptional machinery
Following the discovery of AID, numerous transcription-centric factors have been proposed to contribute to its targeting. An early study suggested an interaction with the RNA polymerase complex based on reciprocal co-immunoprecipitation experiments with AID and RNA polymerase II (Pol II) (116) .
More recently, a study identified the RNA Pol II pausing factor Spt5 in an shRNA screen for factors required in CSR (117) . In support of an interaction between AID and RNA Pol II, Spt5 and AID co-immunoprecipitated in both fibroblasts and CH12 cell lines. The genomic localization of Spt5, defined by CHiP-seq experiments, correlated with regions that had higher rates of mutation in a mouse model overexpressing AID, suggesting a strong correlation between the localization of Spt5 and AID (117) . AID was also shown to interact with components of the splicing machinery; purification of AID complexes identified an interaction with the splicing factor PTBP2 (118) . PTBP2 knockdown experiments revealed this interaction was important for efficient CSR, recalling previous findings on the requirement of processed GLTs (90, 92) .
S region transcripts target AID to the Igh locus
Nearly four decades after the discovery of GLTs, a recent study provided evidence for an Igh-specific factor contributing to AID targeting: the S region transcripts themselves. S μ and S α RNAs transcribed in vitro were found to interact with AID in CH12 extracts, as did aptamer-tagged S α RNAs expressed in vivo (10) . The AID-RNA interaction was specific for transcripts generated in the physiological direction; reverse S μ and S α sequences did not interact with AID. Intriguingly, S μ and S α RNAs were found to fold into G-quadruplex structures that were necessary for their interaction with AID, as disruption of G-quadruplex structure via G to C mutations abolished direct AID binding (10) . Notably, these RNA G-quadruplex structures echoed Sen and Gilbert's discovery of 'G4-DNA' structures within S region DNA sequences (70) . To determine the relevance of the AID-RNA interaction, a single point mutation in AID (G133V) was identified that completely disrupted direct RNA binding to S μ and S α . Importantly, this mutation did not interfere with ssDNA binding or AID deamination of ssDNA in vitro. Expression of AID-G133V was unable to complement IgG1 CSR in AID-deficient primary B cells, and localization of AID G133V to S μ and S γ1 was completely abolished (10) .
These results suggested that direct AID-RNA binding is necessary for targeting AID to S regions, and predicts that depletion of S region transcripts would phenocopy the observed AID-G133V-dependent defect in CSR. To deplete S region transcripts, knock down of the lariat-debranching enzyme DBR1 was hypothesized to interfere with the processing of GLTs and the formation of soluble S region transcripts. Indeed, DBR1 knockdown in CH12 cells resulted in decreased AID localization to S regions as well as decreased IgA CSR. Remarkably, exogenous expression of forward S α , but not reverse, rescued AID localization to S α . Additionally, simultaneous exogenous expression of forward S μ and forward S α , but not their reverse counterparts, rescued IgA CSR (10) .
A model for RNA-dependent AID targeting
In light of these findings, Radbruch and colleagues conclusions 20 years prior proved resoundingly prescient:
'An attractive idea is that the spliced switch transcripts or the spliced intronic switch regions would interact with the recombination machinery. Either in trans, as a component of the switch recombinase, or in cis, rehybridizing with the DNA template.' (92) These data are consistent with a working model whereby processed S region transcripts serve to guide AID to the S regions from which they were transcribed ( Fig. 5A and B) . Splicing of GLTs liberates intronic S region lariats, which are debranched and can fold into G-quadruplex structures, enabling a direct interaction with AID. AID-RNA complexes are then targeted to S region DNA via the base complementarity between the S region transcripts and their DNA templates. In this sense, the proposed mechanism for RNAdependent AID targeting is analogous to the mechanism for guide RNAs targeting Cas9 (119) . This working model elicits many questions, predictions and caveats, which are discussed below. Germline transcripts (GLTs) are transcribed from downstream C H regions upon B cell activation, and undergo splicing to form a processed GLT and an intronic switch (S) region lariat. The S region lariat is debranched to form a linear S region transcript, which can fold into a G-quadruplex secondary RNA structure endowed by the G-richness of S region non-template strand DNA. It is currently unknown if debranching is required for G-quadruplex folding. G-quadruplexes can interact with soluble AID, and AID-RNA complexes are guided to the S region by the strand complementarity between the G-quadruplex and the S region from which it was transcribed (left path). Alternatively, the G-quadruplex can target to the S region independently of AID binding, and then recruit AID via AID-RNA binding (right path). For trans targeting, G-quadruplexes must compete with existing RNA-DNA hybrids for access to template-strand DNA. (B) Targeting of AID-RNA complexes in cis. GLTs are produced from downstream C H regions upon B cell activation; however, they remain attached to their template strand DNA via formation of an R-loop. The GLT undergoes splicing to liberate a processed GLT, while the S region lariat remains annealed as part of the R-loop. Debranching and folding into G-quadruplex secondary RNA structures mediates the recruitment of AID via AID-RNA binding. For cis targeting, G-quadruplexes are not required to compete with RNA-DNA hybrids for access to template-strand DNA; AID, activation-induced cytidine deaminase.
Cis vs trans targeting of AID-RNA complexes S region transcripts can potentially target AID either in cis or in trans. Exogenous expression of S region transcripts was sufficient to rescue CSR in DBR1 knockdown cells (10) , suggesting a trans mechanism is sufficient to support AID-RNA complex targeting to S regions (Fig. 5A ). An important consideration for a trans model is that S region RNA-DNA hybrids are remarkably stable; trans targeting of AID-RNA complexes will have to compete with RNA-DNA hybrids in order to anneal to the template-strand DNA. Alternatively, the RNA exosome, Rnase H or R-loop collapse may expose single-strand template DNA that can be accessed by AID-RNA complexes in trans. Because template and non-template strands are deaminated equally during CSR (102), the template strand must be accessible at some stage of CSR. This particular stage may provide a window for base complementarity to occur between the RNA in the AID-RNA complex, and the template strand DNA.
Another possibility is that AID-RNA complexes are targeted in cis (Fig. 5B) . For this to occur, a region of the unprocessed GLT (presumably part of the S region because of its ability form R-loops) may remain attached to the template-strand DNA as a component of an RNA-DNA hybrid. The remaining regions of the GLT are free to undergo co-transcriptional splicing and debranching, liberating a soluble processed GLT and allowing the S region RNA that is not annealed to fold into a G-quadruplex structure and recruit AID.
Additional roles for the AID-RNA interaction?
As a corollary of having reduced G-density, the AT-rich nontemplate strand of Xenopus S regions is unlikely to support G-quadruplex structures (although this has not been verified experimentally). If this is true, Xenopus S regions cannot utilize a mechanism for AID-RNA complex targeting that relies upon S region RNA binding to AID in a G-quadruplexdependent manner.
Replacement of the endogenous mouse S γ1 region with 4 kb of XS μ was sufficient to support 25% of wild-type CSR levels (107), suggesting that AID was still capable of targeting S regions in the absence of G-quadruplex-containing S transcripts. This suggests that AID deficient in binding G-quadruplex RNA, i.e AID-G133V, should be sufficient to undergo some degree of targeting to S regions and subsequent CSR. Intriguingly, AID-G133V was utterly unable to localize to S regions or rescue CSR in complementation experiments performed in AID-deficient primary B cells. One interpretation of these data is that AID-G133V is unable to utilize an R-loop-independent, RPA-dependent mechanism for targeting S regions. This hypothesis can be tested by determining if AID-G133V is still capable of binding RPA as previously described (109) .
A more interesting interpretation of these data is that AID's interaction with RNA confers an allosteric activation of enzymatic activity, facilitates AID oligomerization or initiates the formation of a multimeric complex containing AID and other components. In either of these scenarios, RNA binding would confer maximal enzymatic activity and efficient CSR. In the context of AID-G133V, the absence of G-quadruplex binding not only results in defective AID targeting, but also renders AID relatively inert due to its inability to undergo allosteric activation, oligomerize or form a multimeric complex. In the case of XS μ replacing mouse S γ1 , AID can still be effectively targeted through non-R-loop RPA-dependent mechanisms and potentially interact with soluble G-quadruplexes and RNAs from different loci in order achieve maximal enzymatic activity.
A thorough biochemical analysis of AID-RNA binding interactions, as well as the effect of RNA binding on AID enzymatic activity, will shed light on the potential for these mechanisms. Importantly, mutations that disrupt either G-quadruplex binding or render AID catalytically inactive will allow for the biochemical dissection of these two separate functions, and provide critical controls. Intriguingly, the working model for RNA-dependent targeting of AID predicts that AID can be targeted to loci outside the Igh locus by exogenously expressing a fusion transcript that contains a G-quadruplex motif for binding AID, and a targeting motif that is complementary to the loci of interest, analogous to CRISPR-Cas9 gene editing. This hypothesis can readily be tested in human or mouse cells lines using fluorescence microscopy.
G-quadruplexes and AID targeting in B cell malignancies
The discovery of S region RNAs interacting with AID was provocative due to the potential Igh locus-specific component endowed by base complementarity targeting. Ironically, while an Igh RNA guide may endow specificity for the Igh locus, the G-quadruplex binding property of AID may permit other loci to spuriously recruit AID by forming G-quadruplex structures. Intriguingly, in vitro transcription of the c-MYC and BCL6 genes, which are both common IGH translocation partners in B cell lymphomas, has been reported to promote R-loop formation, as well as G-quadruplex structures formed within the ssDNA portion of the R-loop, called 'G-loops' (120, 121) . Using electron microscopy, AID was observed to bind to G-loop structures in vitro, suggesting that the G-quadruplex binding property of AID may contribute to aberrant targeting and malignant IGH translocations (121) .
It is possible AID-targeting to c-MYC and BCL6 could be driven by a combination of DNA G-quadruplex and RNA G-quadruplex interactions. Likewise, it is possible that DNA G-quadruplex structures may play a role in targeting AID to the Igh locus. However, in sodium bisulfite experiments analyzing R-loops at S regions, no G-quadruplexes were detected along the exposed G-rich non-template ssDNA. In contrast, a loxP site was readily detected as a short stretch of unmodified bases, by virtue of its stem loop secondary structure protecting paired bases from modification (101) . While further experimentation is needed to confirm these results, current evidence suggests mouse S region G-quadruplexes may be limited to RNA structures. Regardless, AID-G133V will be an invaluable tool to assess the contribution of G-quadruplexes to aberrant AID targeting.
Conclusions
Recounting 40 years of CSR discoveries highlights the complexity of AID targeting. Myriad factors play a role in targeting AID to the Igh locus, including R-loops, splicing, the transcriptional machinery, RPA, the RNA exosome and noncoding S region transcripts. Perplexingly, none of these factors can account for Igh locus-specific localization, but rather localize throughout the genome. A major challenge remains to decipher the remarkable specificity of AID targeting to the Igh locus, and how mistakes might lead to B cell malignancies, which given the high wire nature of CSR and SHM, are much less frequent than would seem likely. Clearly, evolution has taken great interest in minimizing the risk of CSR and SHM, which emphasizes their benefit to survival in a world filled with pathogens and other dangers.
Funding
This work was supported by grants from the National Institutes of Health (1RO1AI072194 and 1RO1AI124186) to J.C. W.T.Y was supported by a T32 training fellowship (4T32CA009149-40).
